Saliba, R M <br/><br/>
B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality.  [electronic resource] 

 -  Bone marrow transplantation  Jul 2017 
 - 1010-1015 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2017.73  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Allografts<br/>B-Cell Activating Factor--blood<br/>Chronic Disease<br/>Disease-Free Survival<br/>Female<br/>Graft vs Host Disease--blood<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Male<br/>Middle Aged<br/>Predictive Value of Tests<br/>Survival Rate